SIDE EFFECTS OF SUNITINIB MANIFESTED ON SKIN OF PATIENTS DIAGNOSED WITH RENAL CELL CARCINOMA: CASE-CONTROL STUDY
Sunitinib is a small, lipophilic, synthetic molecule that interferes with tyrosinekinase domain of vascular endothelial growth factor receptor, and prevents its activation after binding the vascular endothelial growth factor. Both in vitro and in vivo, sunitinib inhibits angiogenesis, and suppress g...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
University in Nis, Faculty of Medicine
2009-10-01
|
Series: | Acta Medica Medianae |
Subjects: | |
Online Access: | http://publisher.medfak.ni.ac.rs/2009-html/3-broj/SIDE%20EFFECTSOF%20SUNITINIB....pdf |